Skip to content
PubMed This is a summary of 105 peer-reviewed journal articles Updated
Oncology

Carcinoid Syndrome: A Patient Guide

At a Glance

Carcinoid syndrome occurs when some neuroendocrine tumors release chemicals such as serotonin into the bloodstream, often after a digestive tract tumor spreads to the liver. Care combines symptom control, tumor-directed treatment, and monitoring for heart valve complications.

Carcinoid Syndrome is a complex medical condition that occurs when specific types of neuroendocrine tumors (NETs) become “functional,” meaning they begin to produce and release bioactive chemicals directly into your bloodstream [1]. While these tumors can originate in various parts of the body, most cases of the syndrome arise when a tumor in the digestive tract has spread to the liver [2]. In a healthy state, the liver acts as a filter that neutralizes these chemicals; however, when tumors take up residence in the liver, they can bypass this filter, allowing substances like serotonin to flood the general circulation [3]. It is important to know that not every functional NET causes the syndrome, and in rare cases, tumors in the lungs or ovaries can produce the syndrome without any liver metastases [3].

The experience of living with Carcinoid Syndrome is often defined by its hallmark symptoms: sudden, dry flushing of the skin and frequent, watery diarrhea [4]. These symptoms are more than just an inconvenience; they are the physical manifestation of your body reacting to a hormonal overload [5]. Because these signs often mimic more common issues like menopause or irritable bowel syndrome, many patients navigate a long journey before receiving a correct diagnosis [6]. Understanding that these episodes have a biological cause is a vital first step in regaining a sense of control over your health [1].

Managing this condition requires a strategy that addresses both the immediate symptoms and the underlying cancer, though these are not always pursued simultaneously [7]. Modern treatment plans typically evaluate blocking the release or production of hormones while also considering targeted therapies—such as surgery, surveillance, systemic therapy, or liver-directed therapy—to stabilize or reduce the size of the tumors [8]. This individualized approach is essential for protecting your long-term health, as chronic exposure to high hormone levels can lead to complications such as Carcinoid Heart Disease, which affects the heart’s valves [9].

While the diagnosis of a rare condition can feel overwhelming, the landscape of care for Carcinoid Syndrome has advanced significantly [10]. With a dedicated multidisciplinary team and a personalized management plan, it is possible to significantly reduce the impact of the syndrome on your daily life [11]. The focus of your care will always be on maintaining your quality of life and ensuring that you have the tools and information necessary to navigate this journey with confidence [12].

Common questions in this guide

What is carcinoid syndrome?
Carcinoid syndrome is a hormone-related condition in which some neuroendocrine tumors release chemicals such as serotonin into the bloodstream. It most often occurs after a digestive tract tumor has spread to the liver, although lung or ovarian tumors can rarely cause it without liver spread.
What are the main symptoms of carcinoid syndrome?
The hallmark symptoms are sudden, dry flushing of the skin and frequent watery diarrhea. Because these symptoms can resemble menopause or irritable bowel syndrome, their connection to a neuroendocrine tumor may not be recognized immediately.
Does every neuroendocrine tumor cause carcinoid syndrome?
No. Only some neuroendocrine tumors are functional and release chemicals that can cause the syndrome, and not every functional tumor causes symptoms. Most cases occur when digestive tract tumors spread to the liver, but rare lung or ovarian tumors may cause the syndrome without liver metastases.
How is carcinoid syndrome treated?
Treatment is individualized and usually addresses both symptoms and the tumor. Doctors may use treatments that block hormone release or production, along with surgery, surveillance, systemic therapy, or liver-directed therapy to control or reduce tumors.
Can carcinoid syndrome affect the heart?
Yes. Long-term exposure to high hormone levels can cause carcinoid heart disease, which affects the heart’s valves. Ask your care team how your heart health will be monitored and how possible complications will be addressed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my current symptom profile suggest that my neuroendocrine tumor is 'functioning' and releasing hormones?
  2. 2.What specific hormone tests and imaging will we use to confirm this diagnosis?
  3. 3.How will we balance treating my daily symptoms, like flushing and diarrhea, with treating the tumor itself?
  4. 4.What steps will we take to monitor my heart health and prevent long-term complications?
  5. 5.Are there specific lifestyle or dietary triggers I should avoid while we begin my treatment plan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Carcinoid Syndrome: A Review.

    Gade AK, Olariu E, Douthit NT

    Cureus 2020; (12(3)):e7186 doi:10.7759/cureus.7186.

    PMID: 32257725
  2. 2

    What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.

    Mulders MCF, de Herder WW, Hofland J

    Endocrine reviews 2024; (45(3)):351-360 doi:10.1210/endrev/bnad035.

    PMID: 38038364
  3. 3

    Primary Ovarian Neuroendocrine Neoplasm With Carcinoid Syndrome and Carcinoid Heart Disease.

    Thammakosol K, Vathesatogkit P, Leelasithorn S, Sriphrapradang C

    Ochsner journal 2026; (26(2)):173-178 doi:10.31486/toj.25.0101.

    PMID: 42311579
  4. 4

    Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease: A Retrospective Multicentric Study of 276 Patients.

    Fijalkowski R, Reher D, Rinke A, et al.

    Neuroendocrinology 2022; (112(6)):547-554 doi:10.1159/000518651.

    PMID: 34348326
  5. 5

    Updates on the biology of serotonin and tryptophan hydroxylase.

    Swami T, Weber HC

    Current opinion in endocrinology, diabetes, and obesity 2018; (25(1)):12-21 doi:10.1097/MED.0000000000000383.

    PMID: 29194046
  6. 6

    Carcinoid syndrome mimicking irritable bowel syndrome: don't fall into the trap.

    Massironi S, Gallo C, Franchina M, et al.

    Expert review of gastroenterology & hepatology 2025; (19(10)):1119-1132 doi:10.1080/17474124.2025.2557245.

    PMID: 40902188
  7. 7

    Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.

    Pokuri VK, Fong MK, Iyer R

    Current oncology reports 2016; (18(1)):7 doi:10.1007/s11912-015-0492-7.

    PMID: 26743514
  8. 8

    Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome.

    Koumarianou A, Daskalakis K, Tsoli M, et al.

    Journal of neuroendocrinology 2022; (34(7)):e13174 doi:10.1111/jne.13174.

    PMID: 35794780
  9. 9

    Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.

    Das S, Stockton SS, Hassan SA

    The oncologist 2023; (28(7)):575-583 doi:10.1093/oncolo/oyad126.

    PMID: 37209415
  10. 10

    Management of carcinoid syndrome: a systematic review and meta-analysis.

    Hofland J, Herrera-Martínez AD, Zandee WT, de Herder WW

    Endocrine-related cancer 2019; (26(3)):R145-R156.

    PMID: 30608900
  11. 11

    TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.

    Strosberg J, Joish VN, Giacalone S, et al.

    The oncologist 2019; (24(11)):1446-1452 doi:10.1634/theoncologist.2018-0921.

    PMID: 31189618
  12. 12

    Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.

    Algeri L, Falkman L, Spada F, et al.

    ESMO open 2024; (9(11)):103959 doi:10.1016/j.esmoop.2024.103959.

    PMID: 39442478

This page is for informational purposes only and does not constitute medical advice. Discuss your symptoms, tumor treatment, and heart monitoring plan with your oncology team.

Get notified when new evidence is published on Carcinoid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.